Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions

v2.4.0.8
Related Party Transactions
3 Months Ended
Sep. 30, 2014
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
10. Related Party Transactions
 
In January 2012, the Company entered into an agreement with Novici Biotech, LLC (“Novici”) in which iBio’s President is a minority stockholder. Novici performs laboratory feasibility analyses of gene expression, protein purification and preparation of research samples. The accounts payable balance includes amounts due to Novici of approximately $222,000 and $38,000 as of September 30, 2014 and June 30, 2014, respectively. Research and development expenses related to Novici were approximately $222,000 and $153,000 for the three months ended September 30, 2014 and 2013, respectively.